Aidi Beike Biopharmaceutical Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 4

Aidi Beike Biopharmaceutical General Information

Description

Developer of genetic medicine designed for virus removal. The company focuses on the research and development of genetic drug using type I CRISPR technology, providing advanced the genetic medicine solution for patients.

Contact Information

Website
www.edibeck.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit B, 8th Floor, Building 1, Phase II, Weiguang Life Science Park
  • Number 669 Beizhen Road, Zhenmei Community, Xinhu Street, Guangming District
  • Shenzhen, Guangdong 518000
  • China
+86 186
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit B, 8th Floor, Building 1, Phase II, Weiguang Life Science Park
  • Number 669 Beizhen Road, Zhenmei Community, Xinhu Street, Guangming District
  • Shenzhen, Guangdong 518000
  • China
+86 186

Aidi Beike Biopharmaceutical Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aidi Beike Biopharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 21-Dec-2025 Completed Generating Revenue
2. Early Stage VC 14-Apr-2025 Completed Generating Revenue
1. Seed Round 27-Feb-2024 $1.4M $1.4M Completed Startup
To view Aidi Beike Biopharmaceutical’s complete valuation and funding history, request access »

Aidi Beike Biopharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cowin Capital Venture Capital Minority
Entropy Capital Asset Manager Minority
Hunan Shangyi Guanxi Asset Management PE/Buyout Minority
Shenzhen Lihe Science and Technology Innovation Venture Capital Minority
To view Aidi Beike Biopharmaceutical’s complete investors history, request access »

Aidi Beike Biopharmaceutical FAQs

  • When was Aidi Beike Biopharmaceutical founded?

    Aidi Beike Biopharmaceutical was founded in 2023.

  • Where is Aidi Beike Biopharmaceutical headquartered?

    Aidi Beike Biopharmaceutical is headquartered in Shenzhen, China.

  • What industry is Aidi Beike Biopharmaceutical in?

    Aidi Beike Biopharmaceutical’s primary industry is Drug Discovery.

  • Is Aidi Beike Biopharmaceutical a private or public company?

    Aidi Beike Biopharmaceutical is a Private company.

  • What is Aidi Beike Biopharmaceutical’s current revenue?

    The current revenue for Aidi Beike Biopharmaceutical is .

  • How much funding has Aidi Beike Biopharmaceutical raised over time?

    Aidi Beike Biopharmaceutical has raised $1.4M.

  • Who are Aidi Beike Biopharmaceutical’s investors?

    Cowin Capital, Entropy Capital, Hunan Shangyi Guanxi Asset Management, and Shenzhen Lihe Science and Technology Innovation have invested in Aidi Beike Biopharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process